Ignite Creation Date:
2024-05-05 @ 4:49 PM
Last Modification Date:
2024-10-26 @ 9:24 AM
Study NCT ID:
NCT00320801
Status:
TERMINATED
Last Update Posted:
2012-09-03
First Post:
2006-04-28
Brief Title:
Buprenorphine Transdermal Patches BTDS in Subjects With Osteoarthritis Pain Includes a 52-week Extension Phase
Sponsor:
Purdue Pharma LP
Organization:
Purdue Pharma LP
Key Dates - Follows AllAPIJSON File Order
Start Date:
2004-01
Start Date Type:
None
Primary Completion Date:
2005-03
Primary Completion Date Type:
ACTUAL
Completion Date:
2005-03
Completion Date Type:
ACTUAL
First Submit Date:
2006-04-28
First Submit QC Date:
April 28 2006
Study First Post Date:
2006-05-03
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2010-09-20
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2012-08-27
Last Update Post Date:
2012-09-03
Last Update Post Date Type:
ESTIMATED